Home
Conditions
Advanced Solid Tumors

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies

Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Completed

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

NCT01110486

Conditions: Advanced Solid Tumors
Locations: Site Reference ID/Investigator# 26525 Chicago, Illinois, United States

Site Reference ID/Investigator# 26524 Houston, Texas, United States

View Trial Details

Completed

An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)

NCT01161836

Conditions: Advanced Solid Tumors
Locations: Northwest Medical Specialties Tacoma, Washington, United States

View Trial Details

Completed

Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors

NCT01017198

Conditions: Advanced Solid Tumors
Locations: Reseach Facility Scottsdale, Arizona, United States

Reseach Facility Encinitas, California, United States

Reseach Facility San Antonio, Texas, United States

View Trial Details

Completed

Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

NCT00793975

Conditions: Advanced Solid Tumors, Neoplasms
Locations: ImClone Investigational Site Aurora, Colorado, United States

ImClone Investigational Site Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors

NCT00842335

Conditions: Advanced Solid Tumors
Locations: Premiere Oncology of Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Study With Atu027 in Patients With Advanced Solid Cancer

NCT00938574

Conditions: Advanced Solid Tumors
Locations: Dept. of Hematology & Med. Oncology, Univ. of Bochum, Marienhospital Herne Herne, Germany

View Trial Details

Completed

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

NCT00996957

Conditions: Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: Acceleron Investigative Site Scottsdale, Arizona, United States

Acceleron Investigative Site Durham, North Carolina, United States

Acceleron Investigative Site Nashville, Tennessee, United States

Acceleron Investigative Site Salt Lake City, Utah, United States

View Trial Details

Completed

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

NCT01472003

Conditions: Advanced Solid Tumors
Locations: Site Reference ID/Investigator# 52203 Heidelberg, Australia

Site Reference ID/Investigator# 58242 Herston, Australia

View Trial Details

Completed

Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors

NCT01055795

Conditions: Advanced Solid Tumors
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Safety and Efficacy of LCL161 in Patients With Solid Tumors

NCT01098838

Conditions: Advanced Solid Tumors, Neoplasms
Locations: UNC/ Lineberger Comprehensive Cancer Center Dept. of LinbergerCancerCtr(2) Chapel Hill, North Carolina, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States

View Trial Details

Advanced Solid Tumors

Advanced Solid Tumors trial results

Related conditions